According to the results of this study, only 2 samples of endometrial adenocarcinoma (2%) showed the expression of GATA3, but the expression of this marker was not observed in any of the ovarian carcinoma samples, as well as normal endometrial and ovarian tissues (10). This evidence concerns the gene GATA3 and ovarian carcinoma.